...expect to produce a preclinical prototype, for which Bayer will fund development, by year end. NeoPath Inc....

...method that uses image-processing computers to identify Pap smears with the highest potential for abnormality. NeoPath Inc....

...its AutoPap 300 QC System, a device for rescreening microscopic images from Pap smear slides. NeoPath Inc....

...review NPTH's PMA for its AutoPap System as a primary screener of Pap smear slides. NeoPath Inc....

...slides. The FDA approved the product last September for quality control rescreening of the slides. NeoPath Inc....

...its AutoPap system, which is used in the quality control rescreening of pap smear slides. NeoPath Inc....

...maintenance, repair and other service, while NPTH will provide Nikon with technical support and training. NeoPath Inc....

...rescreens Pap smear slides initially classified as normal in order to detect potential missed abnormality. NeoPath Inc....

...therapy), Vivus Inc. (VVUS, Menlo Park, Calif., in reproductive), Focal Inc. (Lexington, Mass., in biomaterials), NeoPath Inc....